Dr. Jhansi Reddy, MD

Dr. Reddy practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Reddy's NPI, 1508997453, was assigned on March 9, 2007. Dr. Reddy graduated from New York University School of Medicine in 2005. Dr. Reddy's New York license number on file is 257714.

Dr. Reddy's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Reddy's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Reddy to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207VG0400X. Dr. Reddy is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Reddy's licenses on file in 4 states: New York, Florida, New Jersey and Ohio.

Dmand AI lists menopause, ovarian cyst and vaginal infection among the conditions Dr. Reddy treats.

CMS data shows 199 Medicare services from Dr. Reddy across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $14,325 for them.

CMS counts 106 Medicare patients who saw Dr. Reddy in 2024. The largest group is 65 to 74, with 55 patients. 66% of them have high cholesterol, and 55% have arthritis. Their average risk score is 0.69, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 48, with 95% women.

In 2024, Dr. Reddy wrote 166 Medicare Part D claims for 58 patients. 72% of them were for generic drugs. CMS names the drug for 91 of them, across 4 drugs with 11 or more claims each, at $12,499 in total drug cost. In 2023, CMS named 85 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reddy for performance year 2024, reported through an alternative payment model (APM). Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth.

Dmand AI links 10 papers to Dr. Reddy, published from 2007 to 2014. The most frequent topics are Breast Diseases, Breast Neoplasms and Calcinosis. Dr. Reddy has published most often in Fertil Steril. Dr. Reddy's most frequent co-authors are Lori Jean Mosca, MD, Kutluk H. Oktay, MD, PhD and John Paul Bilezikian, MD.

CMS Open Payments shows 17 general payments to Dr. Reddy from 4 drug and device companies from 2016 to 2017. Consulting fees make up the largest share, 47% of the total. Ferring Pharmaceuticals Inc. paid the most, $3,230.

Dr. Reddy graduated from New York University School of Medicine in 2005.

Dr. Reddy is in network with 11 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.